These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12369170)

  • 21. Air/light-free hyphenated extraction/analysis system: supercritical fluid extraction on-line coupled with liquid chromatography-UV absorbance/electrospray mass spectrometry for the determination of hyperforin and its degradation products in Hypericum pertoratum.
    Wang Z; Ashraf-Khorassani M; Taylor LT
    Anal Chem; 2004 Nov; 76(22):6771-6. PubMed ID: 15538802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of St. John's wort from different Italian regions.
    Pietta P; Gardana C; Pietta A
    Farmaco; 2001; 56(5-7):491-6. PubMed ID: 11482784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of hyperforin a constituent of St. John's wort in plasma by high-performance liquid chromatography.
    Chi JD; Franklin M
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 735(2):285-8. PubMed ID: 10670742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
    Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of the major constituents of St John's wort with HPLC-ESI-MS.
    Chandrasekera DH; Welham KJ; Ashton D; Middleton R; Heinrich M
    J Pharm Pharmacol; 2005 Dec; 57(12):1645-52. PubMed ID: 16354409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
    J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G; Schüle C; Baghai T; Kieser M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison].
    Wurglics M; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2003; 32(3):236-41. PubMed ID: 12784544
    [No Abstract]   [Full Text] [Related]  

  • 29. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
    Kiewert C; Buchholzer ML; Hartmann J; Chatterjee SS; Klein J
    Neurosci Lett; 2004 Jul; 364(3):195-8. PubMed ID: 15196674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
    Charchoglyan A; Abrahamyan A; Fujii I; Boubakir Z; Gulder TA; Kutchan TM; Vardapetyan H; Bringmann G; Ebizuka Y; Beerhues L
    Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study.
    Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC
    J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats.
    Butterweck V; Winterhoff H; Herkenham M
    Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Formulation of St. John's wort extract. A medicinal obstacle course].
    Schmidt PC
    Pharm Unserer Zeit; 2003; 32(3):203-11. PubMed ID: 12784540
    [No Abstract]   [Full Text] [Related]  

  • 34. Three new hyperforin analogues from Hypericum perforatum.
    Shan MD; Hu LH; Chen ZL
    J Nat Prod; 2001 Jan; 64(1):127-30. PubMed ID: 11170687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
    Martínez-Poveda B; Quesada AR; Medina MA
    Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid chromatographic determination of St. John's wort components in functional foods.
    de Jager LS; Perfetti GA; Diachenko GW
    J AOAC Int; 2004; 87(5):1042-8. PubMed ID: 15493659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperforin.
    Beerhues L
    Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro and hydroponic growing system for hypericin, pseudohypericin, and hyperforin production of St. John's wort (Hypericum perforatum CV new stem).
    Murch SJ; Rupasinghe HP; Saxena PK
    Planta Med; 2002 Dec; 68(12):1108-12. PubMed ID: 12494339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.